NCT05940922View on ClinicalTrials.gov

RWE-based Treatment Patterns and Outcomes in CIDP

UnknownOBSERVATIONAL
Enrollment

170

Participants

Timeline

Start Date

August 17, 2023

Primary Completion Date

October 30, 2023

Study Completion Date

October 30, 2023

Conditions
Chronic Inflammatory Demyelinating PolyneuropathyGuillain-Barre SyndromeHereditary Amyloidosis
Interventions
OTHER

No intervention. Retrospective observation only.

No intervention. Retrospective observation only.

Trial Locations (1)

M6 8HD

Northern Care Alliance NHS Foundation Trust, Salford

Sponsors

Collaborators (1)

Alnylam Pharmaceuticals
All Listed Sponsors
collaborator

Alnylam Pharmaceuticals

INDUSTRY

collaborator

Northern Care Alliance NHS Foundation Trust

OTHER

lead

RwHealth

INDUSTRY